Hedgehog Signaling in Oesophageal Cancer After Chemoradiotherapy
Author Information
Author(s): Yoshikawa R, Nakano Y, Tao L, Koishi K, Matsumoto T, Sasako M, Tsujimura T, Hashimoto-Tamaoki T, Fujiwara Y
Primary Institution: Hyogo College of Medicine
Hypothesis
Can Gli-1 expression predict disease progression and prognosis in oesophageal cancer patients undergoing neoadjuvant chemoradiotherapy?
Conclusion
Gli-1 nuclear expression is a strong and independent predictor of early relapse and poor prognosis in oesophageal cancer after chemoradiotherapy.
Supporting Evidence
- Patients with Gli-1 nuclear expression had significantly poorer prognoses than those without.
- All patients with Gli-1 nuclear expression had distant or lymph-node metastasis.
- Statistical analysis showed that distant recurrence was more common in patients with Gli-1 nuclear expression.
Takeaway
This study found that a protein called Gli-1 can help doctors understand how likely it is for oesophageal cancer to come back after treatment.
Methodology
The study analyzed Gli-1 expression in tissue samples from 69 oesophageal cancer patients who underwent chemoradiotherapy and surgery.
Potential Biases
Potential bias in patient selection and retrospective data collection.
Limitations
The study is retrospective and may not account for all variables affecting prognosis.
Participant Demographics
69 patients (11 women and 58 men; mean age 60.7 years; age range 38–78 years).
Statistical Information
P-Value
P=0.001
Confidence Interval
95% CI 1.676–10.104
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website